VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares traded up 36.4% on Friday . The company traded as high as C$0.17 and last traded at C$0.15. 1,722,555 shares changed hands during mid-day trading, an increase of 726% from the average session volume of 208,641 shares. The stock had previously closed at C$0.11.
VentriPoint Diagnostics Price Performance
The stock has a market capitalization of C$24.33 million, a price-to-earnings ratio of -4.63 and a beta of 0.39. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The business has a 50-day simple moving average of C$0.13 and a two-hundred day simple moving average of C$0.12.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- Differences Between Momentum Investing and Long Term Investing
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- What Does Downgrade Mean in Investing?
- Alphabet Enters a Bull Market: Is It Time to Buy?
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
